SCHEMBL19139630

SCHEMBL19139630

CNC(=O)C(C(=O)NO)N(C)C(=O)c1ccc(C#Cc2ccc(C(C)O)cc2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14714360 0.91 — —
SCHEMBL14714552 0.89 — —
SCHEMBL14714793 0.89 — —
SCHEMBL19102863 0.87 — —
SCHEMBL24003263 0.86 — —
SCHEMBL14714821 0.86 — —
SCHEMBL19102801 0.85 — —
SCHEMBL14714455 0.84 — —
SCHEMBL14714347 0.84 — —
SCHEMBL17435473 0.84 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3192505-A1 METHOD FOR USING NOVEL HYDROXAMIC ACID DERIVATIVE AND ANTIBACTERIAL SUBSTANCE IN COMBINATION TOYAMA CHEMICAL CO., LTD. (JP) 2017-07-19 — — EP disclosed
Send feedback